Nexus AG: NEXUS AG signs contract to take over the laboratory information system SWISSLAB

Donaueschingen (pta007/12.10.2018/09:06 UTC+2) NEXUS AG signed a purchase agreement on October 11, 2018, which includes the acquisition of Roche Diagnostics IT Solutions GmbH and the associated laboratory products "SWISSLAB Laboratory Information System" and "LAURIS Order Communication System". The aim of this transaction is to innovate the solutions for existing and new customers and to further increase customer benefit through new product integration.

Under the ownership of Roche, the products SWISSLAB and LAURIS were developed into a leading laboratory solution in Germany and Austria and the expansion in other European countries was successfully started. Today, the products are among the most important laboratory systems in many large hospitals and lab chains in six countries.

For the strategic development of the products, Roche has identified the healthcare software specialist NEXUS AG as a suitable successor organization and plans to transfer the products on 1 December 2018.

Relating on this step, Michael Heuer, CEO of Roche Diagnostics, comments: "We are delighted that NEXUS is taking over Roche Diagnostics Solutions GmbH and its portfolio. From our point of view, NEXUS is optimally positioned for the further development of the product range and the support of the SWISSLAB and LAURIS customers."

NEXUS will complete its diagnostic product range with this acquisition. Customers can do the modern combine hospital information system from NEXUS with a complete diagnostic solution portfolio. SWISSLAB customers will be particularly involved in the integration of NEXUS / HIS, NEXUS / QUALITY MANAGEMENT, be interested in NEXUS / PATHOLOGY and NEXUS / CYTOLOGY.

"We see this step as a great opportunity to offer highly specialized and innovative diagnostic solutions to NEXUS and SWISSLAB customers from a single source and intelligently integrated." comments Ingo Behrendt, CEO of NEXUS AG, the strategic direction of NEXUS.

(end)

Emitter:	Nexus AG Irmastraße 1 78166 Donaueschingen Germany
Contact Person:	Dr. Patrick Stein
Phone:	+49 771 22960-201
E-Mail:	ir@nexus-ag.de
Website:	www.nexus-ag.de
ISIN(s):	DE0005220909 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt, Hamburg; Free Market in Berlin, Dusseldorf, Munich, Stuttgart